Fine Grainded Sentiment Analysis on COVID-19 Vaccine | IEEE Conference Publication | IEEE Xplore

Fine Grainded Sentiment Analysis on COVID-19 Vaccine

Publisher: IEEE

Abstract:

The most talked about topic of interest in the medical realm as of today, is the debate on the impact that COVID-19 vaccine has on individuals, and their response in enco...View more

Abstract:

The most talked about topic of interest in the medical realm as of today, is the debate on the impact that COVID-19 vaccine has on individuals, and their response in encountering the virus. While there are quite a few vaccine variants that have been developed, there has always been a lingering ambiguity in declaring that an individual can be completely immune to the virus. There have been many studies whilom this cognition of analysing the sentiment perception of vaccines, however the data utilization from various sources and the apropos implementation using the language processing methodologies have lagged a great deal. This paper pivots on the data drawn from social media platforms, and optimizes the sentiments using the Natural Language processing Toolkit (NLTK). The process of word embedding, with TFIDF vectorizer commingled with data unsheathing through fine-grained sentiment analysis and machine learning algorithms such as Linear SVC, SVM and Naïve bayes on the covid19 dataset have aided in stratifying the public tweet sentiments based on their polarity, precision, recall, f1-score value and support. The simulations have been implemented using the lexicon, rubric-based analytical tool VADER (Valence Aware Dictionary and sentiment Reasoner) incorporated in Python specifically for optimized extraction of sentiments from data.
Date of Conference: 10-11 December 2021
Date Added to IEEE Xplore: 18 January 2022
ISBN Information:

ISSN Information:

Publisher: IEEE
Conference Location: MORADABAD, India

I. Introduction

The vaccination drive for Covid19 is commenced from January 2021.The two vaccine are used to hinder Covid19 they are Covaxin and Covishield where Covaxin is a bharath biotech vaccine in India and Covishield is Oxford AstraZeneca vaccine .Over nine hundred and seventy three million people are vaccinated in India dated 24 May 2021.In social media lot of opinion is shared about the two vaccine. The public tweet from the twitter API on Covid vaccine is collected from 1st June 2021 to 10 June 2021 to analysis the sentiment of the tweet of people from various region using the classify the sentiment analyser. The aim of the paper is to propose the methodology for ascertaining the public sentiment about the vaccine with more positive tweets.

References

References is not available for this document.